Items where Author or Contributor is "Ali, M Sanni"
 | Up a level |
Number of items: 7.
2019
Hawley, Samuel;
Ali, M Sanni;
Berencsi, Klara;
Judge, Andrew;
Prieto-Alhambra, Daniel;
(2019)
Sample size and power considerations for ordinary least squares interrupted time series analysis: a simulation study.
CLINICAL EPIDEMIOLOGY, 11.
pp. 197-205.
ISSN 1179-1349
DOI: https://doi.org/10.2147/CLEP.S176723
Hawley, Samuel;
Ali, M Sanni;
Cordtz, René;
Dreyer, Lene;
Edwards, Christopher J;
Arden, Nigel K;
Cooper, Cyrus;
Judge, Andrew;
Hyrich, Kimme;
Prieto-Alhambra, Daniel;
(2019)
Impact of TNF inhibitor therapy on joint replacement rates in rheumatoid arthritis: a matched cohort analysis of BSRBR-RA UK registry data.
RHEUMATOLOGY, 58 (7).
pp. 1168-1175.
ISSN 1462-0324
DOI: https://doi.org/10.1093/rheumatology/key424
2018
Khalid, Sara;
Calderon-Larrañaga, Sara;
Hawley, Samuel;
Ali, M Sanni;
Judge, Andrew;
Arden, Nigel;
van Staa, Tjeerd;
Cooper, Cyrus;
Javaid, Muhammad Kassim;
Prieto-Alhambra, Daniel;
(2018)
Comparative anti-fracture effectiveness of different oral anti-osteoporosis therapies based on "real-world" data: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database.
Clinical epidemiology, 10.
pp. 1417-1431.
ISSN 1179-1349
DOI: https://doi.org/10.2147/CLEP.S164112
Losada, E;
Soldevila, B;
Ali, MS;
Martínez-Laguna, D;
Nogués, X;
Puig-Domingo, M;
Díez-Pérez, A;
Mauricio, D;
Prieto-Alhambra, D;
(2018)
Real-world antidiabetic drug use and fracture risk in 12,277 patients with type 2 diabetes mellitus: a nested case-control study.
Osteoporosis international, 29 (9).
pp. 2079-2086.
ISSN 0937-941X
DOI: https://doi.org/10.1007/s00198-018-4581-y
Full text not available from this repository.
Yuan, Hongbo;
Ali, M Sanni;
Brouwer, Emily S;
Girman, Cynthia J;
Guo, Jeff J;
Lund, Jennifer L;
Patorno, Elisabetta;
Slaughter, Jonathan L;
Wen, Xuerong;
Bennett, Dimitri;
+1 more...
ISPE Comparative Effectiveness Research Special Interest Group;
(2018)
Real-World Evidence: What It Is and What It Can Tell Us According to the International Society for Pharmacoepidemiology (ISPE) Comparative Effectiveness Research (CER) Special Interest Group (SIG).
Clinical pharmacology and therapeutics, 104 (2).
pp. 239-241.
ISSN 0009-9236
DOI: https://doi.org/10.1002/cpt.1086
Full text not available from this repository.
2017
Ankarfeldt, Mikkel Zöllner;
Thorsted, Brian Larsen;
Groenwold, Rolf;
Adalsteinsson, Erpur;
Ali, M Sanni;
Klungel, Olaf;
(2017)
Assessment of channeling bias among initiators of glucose-lowering drugs: A UK cohort study.
Clinical Epidemiology, Volume.
pp. 19-30.
DOI: https://doi.org/10.2147/clep.s124054
Ankarfeldt, Mikkel;
Adalsteinsson, Erpur;
Groenwold, Rolf;
Ali, M Sanni;
Klungel, Olaf;
(2017)
A systematic literature review on the efficacy–effectiveness gap: comparison of randomized controlled trials and observational studies of glucose-lowering drugs.
Clinical Epidemiology, Volume.
pp. 41-51.
DOI: https://doi.org/10.2147/clep.s121991